Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That changed after a special on weight loss with experts and clinicians that she taped in July 2023. The panel discussion left her with her “biggest aha moment” about the medication.
Oprah Winfrey Shares What She Learned About “Thin People” After Experience With Weight-Loss Drug
Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin people.”
Novel obesity drug induces up to 22% weight loss with no safety concerns
A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a significant weight reduction compared with placebo, according to top-line results from a phase 1b/2a trial.
Not Just For Weight Loss: GLP-1 Drugs May Affect Addiction And Dementia Risk
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
Oprah Winfrey faces backlash for making bold claim about ‘thin people’ after taking weight-loss drug
"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.
Oprah Winfrey says taking weight loss drugs has changed her opinion of ‘thin people’
Oprah Winfrey is opening up about the impact of taking weight loss drugs on her perspective of “thin people.” During a conversation with Dr Ania Jastreboff on The Oprah Podcast, the 70-year-old admitted that GLP-1 drugs like Ozempic and Wegovy had changed her opinion of thin people.
Oprah Winfrey Slammed for Claiming 'Thin People' Aren't Thinking About Food After Taking Weight-Loss Drug
Oprah Winfrey is opening up about her experience taking weight-loss drug GLP-1. While speaking to guest Dr. Ania Jastreboff on the Tuesday, January 21, episode of “The Oprah Podcast," the talk-show host spilled,
The Internet is Coming for Oprah Because of Her Comments About Thin People and Weight Loss Drugs
The media mogul is being criticized by some for statements she made about thin people on the latest episode of her podcast.
Oprah Winfrey reveals shocking discovery after using weight-loss drug: 'They are not even thinking about it'
Oprah Winfrey is opening up about her experience using weight-loss drugs. The media mogul is sharing some of the realizations she has found after being under an undisclosed GLP-1, which is a type 2 diabetes medication that results in weight loss.
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Popular Weight Loss Drugs Could Affect Your Behavior: Scientists Conduct Genetic Investigation
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
Novo Nordisk reports 22% weight loss in early subcutaneous amycretin trial
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...
Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
Demand for loose skin surgery rises with GLP-1 weight loss meds
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...
Novo Nordisk next-gen shot shows 22% weight loss in early results
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...
Novo Nordisk stock pops on phase I data for new weight-loss drug amycretin
Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...
Diabetes startup Virta Health is now prescribing Ozempic for weight loss in a push toward profitability and IPO
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...